Guggenheim Capital’s Chimerix, Inc. CMRX Stock Holding History

Guggenheim Capital’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23,465	Closed	-$200K	–	1695
2025 Q1	$200K	Buy	+23,465	New	+$129K	﹤0.01%	1538
2016 Q1	–	Sell	-121,120	Closed	-$1.08M	–	3004
2015 Q4	$1.08M	Sell	121,120 -29,746	-20%	-$1.07M	﹤0.01%	2066
2015 Q3	$5.76M	Sell	150,866 -6,379	-4%	-$315K	0.02%	962
2015 Q2	$7.26M	Buy	157,245 +27,501	+21%	+$1.1M	0.02%	986
2015 Q1	$4.89M	Buy	129,744 +18,924	+17%	+$751K	0.01%	1171
2014 Q4	$4.46M	Buy	+110,820	New	+$3.75M	0.01%	1177

Other funds holding CMRX

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Guggenheim Capital's CMRX Position: Q2 2025 in Review

Guggenheim Capital sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 23,465 shares — an estimated $200K sold.

Guggenheim Capital first reported a position in CMRX in Q4 2014 and held it in 6 quarters. The position peaked at $7.26M in Q2 2015. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.

Guggenheim Capital reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
Guggenheim Capital sold 23,465 Chimerix, Inc. shares in Q2 2025, an estimated $200K.
Guggenheim Capital first reported a position in Chimerix, Inc. in Q4 2014 and held it in 6 quarters.
Guggenheim Capital's Chimerix, Inc. position peaked at $7.26M in Q2 2015.
1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.

Based on Guggenheim Capital's 13F filing for Q2 2025, filed 13 Aug 2025.